---
title: "Global Pharmaceutical Grade Licorice Extract Market Research Report 2025, Forecast to 2032"
datePublished: Fri Dec 12 2025 00:28:54 GMT+0000 (Coordinated Universal Time)
cuid: cmj24pwmx000402ie1bobf74t
slug: global-pharmaceutical-grade-licorice-extract-market-research-report-2025-forecast-to-2032-1-1-1

---

# Global Pharmaceutical Grade Licorice Extract Market Research Report 2025, Forecast to 2032

<p>
</p><p><strong>MARKET INSIGHTS</strong></p><p>
</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/282195/global-pharmaceutical-grade-licorice-extract-market">
            https://www.24chemicalresearch.com/download-sample/282195/global-pharmaceutical-grade-licorice-extract-market</a></b></div><br><p>The Global Pharmaceutical Grade Licorice Extract market size was valued at USD 229.80 million in 2024. The market is projected to grow from USD 235.20 million in 2025 to USD 290.75 million by 2032, exhibiting a CAGR of 3.05% during the forecast period.</p><p>
</p><p>Pharmaceutical grade licorice extract is a standardized botanical preparation derived from Glycyrrhiza glabra roots, containing minimum 4% glycyrrhizin content as per pharmacopeial standards. This highly purified extract finds extensive application in cough syrups, digestive aids, and dermatological formulations due to its anti-inflammatory, demulcent, and hepatoprotective properties. Recent innovations include the development of deglycyrrhizinated licorice (DGL) variants for hypertension-sensitive populations.</p><p>
</p><p>The market growth is primarily driven by increasing demand for herbal APIs in respiratory therapeutics, where licorice extract commands 38% of the botanical ingredients market segment. However, supply chain volatility in major producing regions like China and Iran, coupled with stringent EMA/FDA compliance requirements, pose challenges for market players. Strategic developments such as Maruzen Pharmaceuticals' 2024 acquisition of Iranian licorice farms demonstrate industry efforts to secure raw material supply chains.</p><p>

<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Demand for Herbal Remedies in Respiratory Care to Accelerate Market Expansion</strong></p><p>
</p><p>The global pharmaceutical grade licorice extract market is experiencing robust growth, primarily driven by increasing consumer preference for herbal medicine in respiratory care applications. Respiratory medications currently account for approximately 40% of total market share, with the segment projected to maintain steady growth through 2032. Licorice's natural anti-inflammatory and expectorant properties make it particularly valuable in cough syrups, throat lozenges, and bronchitis treatments. Recent clinical studies have validated its efficacy in reducing upper respiratory tract inflammation, leading to greater adoption by pharmaceutical manufacturers. The standardized extract form commands market premiums of about 35% over conventional extracts due to its guaranteed glycyrrhizin content and pharmaceutical-grade purity.</p><p>
</p><p style="text-align:center"><strong>Asian Traditional Medicine Influence Creates Sustained Demand</strong></p><p>
</p><p>Asia Pacific dominates the pharmaceutical licorice extract market with a 45% revenue share, a position maintained through deep-rooted traditional medicine practices. Countries like China, Japan, and India continue integrating licorice into modern pharmaceutical formulations while preserving ancient therapeutic applications. This dual demand scenario creates stable market growth with compound annual growth rates averaging 3.2% in the region. Major manufacturers are investing in GMP-certified extraction facilities across Asia to capitalize on both domestic demand and export opportunities, particularly for standardized extracts meeting European and North American pharmacopeia standards.</p><p>

</p><p><strong>âž¤ The Japanese Pharmacopoeia recently revised its monographs for licorice extracts in 2023 to include more rigorous testing for heavy metals and pesticide residues, creating new quality benchmarks for global suppliers.</strong></p><p>
</p><p>Digital pharmacies specializing in herbal medicine have further accelerated market penetration, with online sales of licorice-based pharmaceuticals growing at 12% annually since 2022. This distribution channel innovation complements traditional pharmaceutical supply chains while reaching younger demographics.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Glycyrrhizin-Related Side Effects Pose Regulatory Challenges</strong></p><p>
</p><p>While licorice extract offers significant therapeutic benefits, its glycyrrhizin content presents notable regulatory hurdles. Chronic consumption exceeding 100mg/day of glycyrrhizin may lead to pseudohyperaldosteronism, prompting strict dosage guidelines in pharmaceuticals. The European Medicines Agency recently updated its herbal medicine guidelines to include more prominent warnings about prolonged licorice consumption, potentially limiting some therapeutic applications. Compliance with these evolving regulations increases product development costs by an estimated 15-20% for manufacturers targeting multiple geographic markets.</p><p>
</p><p>Additionally, batch-to-batch consistency in glycyrrhizin concentration remains technically challenging despite advanced extraction technologies. This variability complicates dosage standardization in finished pharmaceutical products, requiring additional quality control measures that elevate production costs across the value chain.</p><p>
</p><p style="text-align:center"><strong>Climate Change Impacts on Raw Material Supply</strong></p><p>
</p><p>Licorice root cultivation faces growing environmental pressures, with key producing regions in Northwest China and Mediterranean countries experiencing increased drought frequency. Soil degradation in traditional growing areas has reduced average root yields by approximately 8% over the past decade while increasing cultivation costs. These agricultural challenges create supply chain vulnerabilities for pharmaceutical manufacturers dependent on consistent, high-quality raw materials. Some producers are exploring vertical integration strategies, including contracted farming agreements with quality incentives, to secure their supply chains against these environmental and economic pressures.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Innovative Formulations in Digestive Health Present Growth Potential</strong></p><p>
</p><p>The digestive health segment represents the fastest-growing application for pharmaceutical licorice extracts, expanding at 7.8% CAGR through 2032. Modern research has validated licorice's gastroprotective effects, particularly its ability to support mucosal lining repair. This scientific validation is driving innovation in combination therapies for GERD and peptic ulcers, where licorice extract complements conventional proton pump inhibitors. Pharmaceutical companies are actively patenting novel delivery systems, including gastro-resistant tablets and sustained-release capsules, to enhance licorice's therapeutic effects in digestive applications.</p><p>
</p><p>Emerging markets show particular promise, with digestive health supplement sales incorporating licorice extracts growing at double-digit rates in Southeast Asia and Latin America. Meanwhile, Western markets are seeing increased adoption of licorice-based pharmaceuticals as part of integrated approaches to manage functional gastrointestinal disorders.</p><p>
</p><p style="text-align:center"><strong>Strategic Investments in Sustainable Sourcing Create Competitive Advantage</strong></p><p>
</p><p>Leading manufacturers are differentiating through sustainability initiatives in licorice cultivation. Investments in agroforestry systems that combine licorice with complementary crops can improve soil health while increasing farmer incomes by up to 30%. Such programs not only secure long-term raw material supplies but also cater to pharmaceutical companies' increasing emphasis on sustainable sourcing in their ESG commitments. Vertical integration strategies are proving particularly effective, with some manufacturers achieving 15-20% cost reductions through direct farm partnerships and optimized extraction processes.</p><p>
</p><p>The growing nutraceutical sector also presents expansion opportunities, as licorice extracts gain recognition for supporting adrenal function and stress management. Clinical research into licorice's adaptogenic properties is opening new avenues for FDA-approved supplements targeting cortisol regulation and metabolic health.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Stringent Quality Control Requirements Elevate Production Costs</strong></p><p>
</p><p>Pharmaceutical-grade licorice extracts face significantly more rigorous quality standards than food or cosmetic grades, requiring advanced testing for contaminants and precise standardization of active compounds. Meeting pharmacopeia specifications for heavy metals, pesticide residues, and microbial limits increases production costs by approximately 25-35% compared to conventional extracts. These stringent requirements create substantial barriers to entry for new market participants while pressuring margins across the industry.</p><p>
</p><p>Analytical method validation presents another technical challenge, particularly for smaller manufacturers. The complexity of accurately quantifying multiple bioactive compounds (glycyrrhizin, liquiritin, and isoliquiritin) requires sophisticated HPLC equipment and specialized expertise, with analytical costs consuming 8-12% of total production expenses for premium-grade extracts.</p><p>
</p><p style="text-align:center"><strong>Competition from Synthetic Alternatives Intensifies</strong></p><p>
</p><p>While natural licorice extracts maintain preference in many traditional medicine applications, synthetic alternatives are gaining traction in pharmaceutical formulations. Carbenoxolone, a synthetic derivative of glycyrrhizic acid, offers more consistent dosing and fewer side effects in certain therapeutic applications. However, these synthetic alternatives currently command prices 40-50% higher than natural extracts, limiting their market penetration. Manufacturers must balance the benefits of natural sourcing against the dosing precision offered by synthetic options, particularly in Western markets where pharmaceutical consistency standards are most stringent.</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Strategic Expansions and Product Innovations Drive Market Competition</strong></p><p>
</p><p>The global pharmaceutical grade licorice extract market features a competitive yet fragmented landscape, with established players and regional specialists vying for market share. <strong>Magnasweet</strong> has emerged as a dominant force, leveraging its patented glycyrrhizin isolation technology and comprehensive distribution network across North America and Europe. The company captured approximately 18% of the market share in 2024 through its high-purity extract formulations.</p><p>
</p><p><strong>Zagros Licorice</strong> and <strong>Sepidan Osareh</strong> represent strong regional competitors, collectively controlling nearly 25% of Middle Eastern and Asian markets. Their competitive edge stems from direct access to raw licorice root cultivation and cost-efficient production facilities in Iran, which supplies nearly 40% of global licorice root material.</p><p>
</p><p>Recent strategic movements include <strong>F&amp;C Licorice's</strong> 2024 acquisition of VPL Chemicals' extraction division, expanding its production capacity by 30%. Meanwhile, <strong>Norevo GmbH</strong> has strengthened its European foothold through a technology-sharing agreement with Maruzen Pharmaceuticals, enhancing its standardized extract formulations.</p><p>
</p><p>The market has witnessed increasing consolidation as mid-sized players like <strong>Ransom Naturals</strong> and <strong>Aushadhi Herbal</strong> pursue vertical integration strategies. Several companies have shifted focus toward organic and sustainable sourcing practices to meet evolving pharmaceutical industry standards.</p><p>
<strong>List of Key Pharmaceutical Grade Licorice Extract Companies Profiled</strong></p><p>
</p><p>Magnasweet (U.S.)</p><p>Zagros Licorice (Iran)</p><p>Sepidan Osareh (Iran)</p><p>F&amp;C Licorice (U.S.)</p><p>Norevo GmbH (Germany)</p><p>Ransom Naturals Ltd. (India)</p><p>Maruzen Pharmaceuticals (Japan)</p><p>Aushadhi Herbal Pvt. Ltd. (India)</p><p>Avestia Pharma (U.S.)</p><p>VPL Chemicals Pvt. Ltd. (India)</p><p>

</p><p>
<strong>PHARMACEUTICAL GRADE LICORICE EXTRACT MARKET TRENDS</strong></p><p>
<strong>Rising Demand for Natural Therapeutics Drives Market Growth</strong></p><p>
</p><p>The global pharmaceutical grade licorice extract market is experiencing significant traction due to <strong>increasing consumer preference for plant-based and natural therapeutics</strong>. Licorice extracts exhibit anti-inflammatory, antiviral, and hepatoprotective properties, making them valuable in formulations for respiratory, digestive, and dermatological applications. The market is projected to grow at a <strong>CAGR of 2.40% from 2025 to 2032</strong>, with respiratory applications alone capturing <strong>40% of market share</strong> owing to the efficacy of glycyrrhizin in managing bronchial conditions. This growth is further supported by clinical validations demonstrating licorice's synergistic effects when combined with conventional drugs.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Standardization and Quality Control Innovations</strong></p><p>
</p><p>Pharmaceutical manufacturers are increasingly investing in <strong>advanced extraction and purification technologies</strong> to meet stringent pharmacopoeia standards. The implementation of HPLC and mass spectrometry for glycyrrhizin content verification has become critical, with standardized extracts commanding a <strong>35% price premium</strong> over conventional variants. Regulatory bodies in key markets now mandate detailed phytochemical profiling, pushing companies to adopt <strong>Good Manufacturing Practice (GMP)-certified processes</strong> that ensure batch-to-batch consistency in active compound concentrations.</p><p>
<strong>Asia-Pacific Dominance in Traditional Medicine Integration</strong></p><p>
</p><p>The Asia-Pacific region currently represents <strong>45% of global demand</strong> for pharmaceutical grade licorice extract, driven by deep-rooted applications in Traditional Chinese Medicine (TCM) and Ayurveda. Countries like China and India are witnessing <strong>7-8% annual growth</strong> in licorice-based digestive health formulations, with concurrent expansion in export-oriented processing facilities. Government initiatives supporting herbal medicine research and the establishment of <strong>regional testing laboratories</strong> for quality certification are further consolidating the region's position as both a production hub and consumption center.</p><p>

Regional Analysis: Global Pharmaceutical Grade Licorice Extract Market</p><p>

  Asia-Pacific
  
    Asia-Pacific dominates the global pharmaceutical grade licorice extract market, accounting for nearly half of worldwide consumption. This dominance stems from centuries-old traditional medicine systems like Ayurveda and Traditional Chinese Medicine that extensively use licorice root extracts. Countries like China, India, Japan, and South Korea have deeply integrated traditional medicine with modern pharmaceutical industries, creating substantial domestic demand. The region also benefits from favorable climate conditions for Glycyrrhiza glabra cultivation and has developed sophisticated extraction and purification technologies that meet international pharmaceutical standards. Regulatory frameworks across the region actively support herbal medicine integration into mainstream healthcare, further driving market growth.
  
</p><p>

  
    
      Traditional Medicine Integration</p><p>
      Asia-Pacific countries have successfully integrated traditional knowledge systems with modern pharmaceutical regulations, allowing traditional practitioners and modern manufacturers to collaborate on licorice extract applications. This integration enables traditional knowledge to inform modern therapeutic development while ensuring standardised quality control.
    
    
      Manufacturing Expertise</p><p>
      The region has developed sophisticated Good Manufacturing Practice (GMP) compliant facilities specifically for herbal extracts. Countries like India, China, and South Korea have established specialised facilities for phytopharmaceutical production that meet international regulatory standards while maintaining traditional knowledge foundations.
    
    
      Regulatory Harmonisation</p><p>
      Regulatory bodies across the region have developed standardised testing and certification processes specifically for herbal extracts used in pharmaceutical applications. This includes standardised chromatography methods, heavy metal testing, and microbial contamination standards that meet both regional traditional medicine standards and international pharmaceutical requirements.
    
    
      Research and Development</p><p>
      Significant public and private investment in research on traditional medicine applications has led to innovative extraction methods and new applications for licorice extracts. Research institutions collaborate closely with traditional medicine practitioners to document and standardise traditional knowledge while applying modern scientific validation methods.
    
  
</p><p>
</p><p><strong>North America</strong></p><p>
North America maintains rigorous quality control standards for pharmaceutical grade licorice extract, with the United States Food and Drug Administration and Health Canada establishing detailed guidelines for herbal supplement and pharmaceutical ingredient quality. The market is characterised by high consumer awareness about herbal medicine safety and strong demand for standardised extracts with documented efficacy. The region has developed advanced testing facilities to verify purity and concentration levels, while regulatory frameworks ensure that imported products from Asia and elsewhere meet North American standards. The market shows strong growth in integrative medicine approaches where licensed physicians incorporate traditional remedies alongside conventional treatments.</p><p>
</p><p><strong>Europe</strong></p><p>
European markets maintain some of the world's strictest regulations for herbal medicinal products, with the European Medicines Agency providing detailed guidance on traditional herbal medicinal products. Countries like Germany, France, and the UK have integrated traditional medicine into their national healthcare systems while maintaining rigorous safety standards. The market shows particular strength in Central and Eastern European countries where traditional herbal knowledge remains strong. European manufacturers have developed sophisticated extraction and standardisation technologies that maintain bioactive compound profiles while ensuring batch-to-batch consistency. The market shows steady growth particularly in integrative oncology and digestive health applications.</p><p>
</p><p><strong>Latin America</strong></p><p>
Latin American markets show growing interest in traditional and complementary medicine, with countries like Brazil, Mexico, and Argentina developing regulatory frameworks for herbal products that combine traditional knowledge with modern safety standards. The region benefits from native Glycyrrhiza species and traditional knowledge systems that predate European contact. Current market development focuses on integrating traditional medicine into public health systems while establishing quality control mechanisms that meet both traditional practitioners' expectations and modern regulatory requirements. Regional collaborations help harmonise standards across countries.</p><p>
</p><p><strong>Middle East and Africa</strong></p><p>
While smaller than other regions, the market shows significant growth potential particularly in countries with strong traditional medicine systems like Iran, Turkey, and South Africa. These markets often blend traditional knowledge with modern regulatory approaches, creating unique regulatory frameworks. The region shows increasing interest in standardised traditional medicine integration into national health systems, with several countries establishing dedicated traditional medicine regulatory bodies. Market growth is supported by both traditional practitioners and modern manufacturers seeking to preserve traditional knowledge while meeting contemporary safety standards.</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Pharmaceutical Grade Licorice Extract, covering the period from 2025 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Pharmaceutical Grade Licorice Extract companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Pharmaceutical Grade Licorice Extract Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The Global Pharmaceutical Grade Licorice Extract Market was valued at <strong>USD 219.60 million in 2025</strong> and is expected to reach <strong>USD 271.85 million by 2032</strong>.</p><p>
<strong>Which key companies operate in Global Pharmaceutical Grade Licorice Extract Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Magnasweet, Zagros Licorice, Sepidan Osareh, F&amp;C Licorice, and Norevo GmbH</strong>, among others.</p><p>
<strong>What are the key growth drivers of Global Pharmaceutical Grade Licorice Extract Market?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for respiratory medications (40% market share) and 7.8% growth in digestive health applications</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> is the fastest-growing region, while <strong>Asia Pacific</strong> remains a dominant market with 45% share.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>standardized extracts commanding 35% premium and integration with traditional medicine practices</strong>.</p><p>

</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/282195/global-pharmaceutical-grade-licorice-extract-market">
            https://www.24chemicalresearch.com/reports/282195/global-pharmaceutical-grade-licorice-extract-market</a></b></div><br>
            <b>Table of Content:</b><p>Table of Contents<br />
1 Research Methodology and Statistical Scope<br />
1.1 Market Definition and Statistical Scope of Pharmaceutical Grade Licorice Extract<br />
1.2 Key Market Segments<br />
1.2.1 Pharmaceutical Grade Licorice Extract Segment by Type<br />
1.2.2 Pharmaceutical Grade Licorice Extract Segment by Application<br />
1.3 Methodology & Sources of Information<br />
1.3.1 Research Methodology<br />
1.3.2 Research Process<br />
1.3.3 Market Breakdown and Data Triangulation<br />
1.3.4 Base Year<br />
1.3.5 Report Assumptions & Caveats<br />
2 Pharmaceutical Grade Licorice Extract Market Overview<br />
2.1 Global Market Overview<br />
2.1.1 Global Pharmaceutical Grade Licorice Extract Market Size (M USD) Estimates and Forecasts (2019-2032)<br />
2.1.2 Global Pharmaceutical Grade Licorice Extract Sales Estimates and Forecasts (2019-2032)<br />
2.2 Market Segment Executive Summary<br />
2.3 Global Market Size by Region<br />
3 Pharmaceutical Grade Licorice Extract Market Competitive Landscape<br />
3.1 Global Pharmaceutical Grade Licorice Extract Sales by Manufacturers (2019-2025)<br />
3.2 Global Pharmaceutical Grade Licorice Extract Revenue Market Share by Manufacturers (2019-2025)<br />
3.3 Pharmaceutical Grade Licorice Extract Market Share by Company Type (Tier 1, Tier 2, and Tier 3)<br />
3.4 Global Pharmaceutical Grade Licorice Extract Average Price by Manufacturers (2019-2025)<br />
3.5 Manufacturers Pharmaceutical Grade Licorice Extract Sales Sites, Area Served, Product Type<br />
3.6 Pharmaceutical Grade Licorice Extract Market Competitive Situation and Trends<br />
3.6.1 Pharmaceutical Grade Licorice Ext</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/282195/global-pharmaceutical-grade-licorice-extract-market">
            https://www.24chemicalresearch.com/reports/282195/global-pharmaceutical-grade-licorice-extract-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>